PT2517700E - Cocristais farmaceuticamente aceitáveis de n-[2-(7-metoxi- 1-naftil)etil]acetamida e métodos para a sua preparação - Google Patents

Cocristais farmaceuticamente aceitáveis de n-[2-(7-metoxi- 1-naftil)etil]acetamida e métodos para a sua preparação

Info

Publication number
PT2517700E
PT2517700E PT110750734T PT11075073T PT2517700E PT 2517700 E PT2517700 E PT 2517700E PT 110750734 T PT110750734 T PT 110750734T PT 11075073 T PT11075073 T PT 11075073T PT 2517700 E PT2517700 E PT 2517700E
Authority
PT
Portugal
Prior art keywords
pharmaceutically acceptable
methods
acetamide
naphthyl
methoxy
Prior art date
Application number
PT110750734T
Other languages
English (en)
Inventor
Jindrich Richter
Gary James Miller
Ludek Ridvan
Ondrej Dammer
Tomas Chvojka
Tomas Pekarek
Winfried Heyse
Norbert Nagel
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of PT2517700E publication Critical patent/PT2517700E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/145—Maleic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
PT110750734T 2011-04-28 2011-04-28 Cocristais farmaceuticamente aceitáveis de n-[2-(7-metoxi- 1-naftil)etil]acetamida e métodos para a sua preparação PT2517700E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11075073.4A EP2517700B1 (en) 2011-04-28 2011-04-28 Pharmaceutically acceptable cocrystals of N-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation

Publications (1)

Publication Number Publication Date
PT2517700E true PT2517700E (pt) 2013-10-14

Family

ID=44519907

Family Applications (1)

Application Number Title Priority Date Filing Date
PT110750734T PT2517700E (pt) 2011-04-28 2011-04-28 Cocristais farmaceuticamente aceitáveis de n-[2-(7-metoxi- 1-naftil)etil]acetamida e métodos para a sua preparação

Country Status (16)

Country Link
US (1) US8927771B2 (pt)
EP (1) EP2517700B1 (pt)
JP (1) JP5770928B2 (pt)
KR (1) KR20140008370A (pt)
CN (1) CN103501777B (pt)
BR (1) BR112013023471A2 (pt)
EA (1) EA024422B1 (pt)
ES (1) ES2429348T3 (pt)
IL (1) IL228916A (pt)
MX (1) MX342807B (pt)
PL (1) PL2517700T3 (pt)
PT (1) PT2517700E (pt)
RS (1) RS52982B (pt)
UA (1) UA111844C2 (pt)
WO (1) WO2012146371A1 (pt)
ZA (1) ZA201307688B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12012000132B1 (en) 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
EP2551257A1 (en) * 2011-07-28 2013-01-30 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of agomelatine with co-crystal-formers
WO2013170738A1 (zh) * 2012-05-14 2013-11-21 上海右手医药科技开发有限公司 阿戈美拉汀酸根复合物及其制备方法和用途
US10098859B2 (en) 2012-09-05 2018-10-16 Amri Ssci, Llc Cocrystals of p-coumaric acid
EP2743255B1 (en) 2012-12-17 2016-06-22 Dr. Reddy's Laboratories Ltd. Cocrystal of agomelatine with phosphoric acid
PL2810656T3 (pl) 2013-06-06 2018-01-31 Zentiva Ks Preparaty agomelatyny zawierające agomelatynę w postaci kokryształów
EP2810647A1 (en) * 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
FR3012142B1 (fr) * 2013-10-17 2016-07-15 Servier Lab Nouveaux complexes d'agomelatine et d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SI3027588T1 (sl) * 2013-07-29 2020-08-31 Les Laboratoires Servier Kompleksi agomelatina in sulfonskih kislin, postopek za pripravo le-teh in farmacevtskih sestavkov, ki jih vsebujejo
WO2015013865A1 (en) * 2013-07-29 2015-02-05 Les Laboratoires Servier Agomelatine sulfonic acids complexes and preparation thereof
WO2015013903A1 (en) * 2013-07-31 2015-02-05 Les Laboratoires Servier NEW AGOMELATINE p-TOLUENESULFONIC ACID CO-CRYSTAL FORMS AND PREPARATION THEREOF
ES2734562T3 (es) * 2013-07-31 2019-12-10 Servier Lab Co-cristales de agomelatina y ácido p-toluensulfónico, su procedimiento de preparación y composiciones farmacéuticas que los contienen
CN105473551B (zh) * 2013-07-31 2019-01-11 法国施维雅药厂 阿戈美拉汀和对甲苯磺酸的共晶的新形式、其制备方法和包含其的药物组合物
KR101404836B1 (ko) 2014-03-21 2014-06-09 순천향대학교 산학협력단 아고멜라틴의 공결정 및 그의 제조방법
KR101470794B1 (ko) 2014-06-30 2014-12-08 순천향대학교 산학협력단 아고멜라틴 공결정의 제조 방법 및 이를 포함하는 조성물
ES2959460T3 (es) 2015-03-31 2024-02-26 Fis Fabbrica Italiana Sintetici Spa Forma sólida de agomelatina
WO2017115284A1 (en) * 2015-12-28 2017-07-06 Leiutis Pharmaceuticals Pvt, Ltd. Novel co-crystal forms of agomelatine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2514733A1 (en) * 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
WO2008035177A2 (en) * 2006-09-18 2008-03-27 Copharm Combination of mt1 and mt2 melatonin receptor agonists and a norepinephrine/dopamine reuptake inhibitor
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
CN102106806B (zh) * 2009-12-29 2013-04-17 上海中西制药有限公司 一种固体制剂的制备方法及所得固体制剂
WO2012046253A2 (en) * 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms
PH12012000132B1 (en) * 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
UA111844C2 (uk) 2016-06-24
EA024422B1 (ru) 2016-09-30
US8927771B2 (en) 2015-01-06
BR112013023471A2 (pt) 2016-12-13
CN103501777A (zh) 2014-01-08
EP2517700A1 (en) 2012-10-31
JP5770928B2 (ja) 2015-08-26
EA201391574A1 (ru) 2014-04-30
US20140051887A1 (en) 2014-02-20
PL2517700T3 (pl) 2013-12-31
MX2013012103A (es) 2014-01-24
ES2429348T3 (es) 2013-11-14
IL228916A (en) 2016-05-31
KR20140008370A (ko) 2014-01-21
JP2014522388A (ja) 2014-09-04
WO2012146371A1 (en) 2012-11-01
RS52982B (en) 2014-02-28
IL228916A0 (en) 2013-12-31
ZA201307688B (en) 2015-04-29
CN103501777B (zh) 2015-08-19
EP2517700B1 (en) 2013-07-17
MX342807B (es) 2016-10-13

Similar Documents

Publication Publication Date Title
PT2517700E (pt) Cocristais farmaceuticamente aceitáveis de n-[2-(7-metoxi- 1-naftil)etil]acetamida e métodos para a sua preparação
IL260297A (en) Process for preparing n-[5-(5,3-difluoro-benzyl)-h1-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino )–benzamide
EP2705023A4 (en) PROCESSES FOR THE PREPARATION OF N- [2- (7-METHOXY-1-NAPHTHYLLELYHYL) ACETAMIDE
MD20120050A2 (en) New agomelatine cocrystals, process for their preparation and pharmaceutical compositions containing them
IN2015KN00262A (pt)
WO2014041565A3 (en) Improved process for preparation of vilanterol and intermediates thereof
WO2013098833A3 (en) Processes and intermediates for preparing rivaroxaban
HK1197414A1 (zh) 雌甾- -四烯- -甲酰胺衍生物、其製備方法、包含其的藥物製劑及其用於製備藥物的用途
IL222999A (en) Process for the preparation of pluromutilins, intermediates and pharmaceutical preparations containing pluromutilins
CL2011001405A1 (es) Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina.
WO2013093931A3 (en) Novel prodrugs of phenolic drugs
HUP1100701A2 (en) Novel process for the preparation of travoprost
EP2697238A4 (en) SOLID FORMS OF ANTIRETROVIRUS COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITION
MX2012008413A (es) Composicion novedosa de retigabina.
EP2773610A4 (en) DEODODING PROCESS FOR PREPARING AROMATIC 3,5-DISUBSTITUTED 2,4,6-TRIJOD AMINE COMPOUNDS
NZ701103A (en) Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide
MA35002B1 (fr) Forme cristalline delta du sel d'arginine du périndopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
HK1178881A1 (en) New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
GEP20094746B (en) Use of agomelatine to obtain medication aimed at treating smith-magenis syndrome
EA201201123A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения обсессивно-компульсивного расстройства (окр)
IL222799A0 (en) Novel process for the preparation of nitrogen substituted aminotetralins derivatives
EP2677868A4 (en) PHARMACEUTICAL COMPOSITIONS OF MARAVIROC AND METHOD OF PREPARING THEM
MD20160072A2 (ro) Procedeu nou de sinteză a 7-metoxi-naftalină-1-carbaldehidei şi aplicarea acesteia în sinteza agomelatinei
IN2013MU01336A (pt)
PL396024A1 (pl) Sposób wytwarzania 4,2',4' -trihydroksy-6'-metoksy-3'-prenylo-α,ß-dihydrochalkonu